​

Funding Round

Series B - Flare Therapeutics

Series B - Flare Therapeutics

Investment Firm

Overview

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Announced Date

Mar 22, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Pfizer Venture Investments

Pfizer Venture Investments

Pfizer Venture Investments is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

GordonMD Global Investments

GordonMD Global Investments

GordonMD Global Investments is a early_stage_venture and post_ipo firm.

Participant Investors

11

Investor Name
Participant InvestorMemorial Sloan - Kettering Cancer Center
Participant InvestorEli Lilly
Participant InvestorInvus
Participant InvestorNovartis
Participant InvestorThird Rock Ventures

Round Details and Background

Flare Therapeutics raised $123000000 on 2023-03-22 in Series B

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 13, 2021
Series A - Flare Therapeutics
6-82.0M
Mar 22, 2023
Series B - Flare Therapeutics
14-123.0M

Recent Activity

There is no recent news or activity for this profile.